NUTTER Lauryl M. J.
Lauryl Nutter trained as a geneticist at the University of Calgary working with Drosophila. After obtaining her doctorate in 1997, she moved to Toronto, first as a post-doctoral fellow and then a research associate at The Hospital for Sick Children. At SickKids, her research used mouse models of pre-B cell leukemia to look at leukemogenesis and the genetic factors enabling leukemia to invade the central nervous system. In 2007, Lauryl joined the management team at The Centre for Phenogenomics (TCP) where she directed the Molecular Biology and Cryopreservation and Recovery Cores until early 2019. In this role, Dr. Nutter established the methodology for mouse and rat model production using CRISPR/Cas9-based genome editing. Dr. Nutter also Co-Chairs the Cas9 Working Group and the Immunophenotyping Working Group for the International Mouse Phenotyping Consortium. Dr. Nutter is now the Senior Director, Science and Technology Development at TCP.